Previous 10 | Next 10 |
2024-01-09 16:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-08 09:42:56 ET More on LivaNova PLC LivaNova: Reaching End Of RECOVER And ANTHEM LivaNova PLC (LIVN) Q3 2023 Earnings Call Transcript LivaNova PLC 2023 Q3 - Results - Earnings Call Presentation LivaNova reports cybersecurity incident, says IT systems ...
Move Reinforces Focus on Core Cardiopulmonary and Neuromodulation Businesses ACS Standalone Cannulae Products and Accessories to Transition Into Cardiopulmonary Business Unit LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that it will c...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its fourth-quarter and full-year 2023 results on Wednesday, February 21, 2024 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its fourth-quarter and full-year 202...
2023-12-26 18:00:00 ET Summary LivaNova is approaching the end of the ANTHEM and RECOVER which could dramatically change the company profile. In cardiopulmonary results are great with a new product launch of Essenz taking market share at premium prices. Run-rate PEs aren't tha...
2023-12-17 07:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-12-07 22:08:36 ET Summary Greenlight Capital's 13F portfolio value decreased by 17% to $1.76 billion in Q3 2023. New stakes were established in DHT Holdings and Herc Holdings. Stake disposals include Black Knight Inc. and Capri Holdings, among others. This artic...
2023-11-20 18:07:59 ET LivaNova ( NASDAQ: LIVN ) disclosed in an SEC filing on Monday that it has detected a cybersecurity incident that disrupted portions of its IT systems. The incident has caused, and is expected to continue to cause, disruption to parts of the company’...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Bill Kozy, Interim Chief Executive Officer and Board Chair of LivaNova, will present in a fireside chat at the Piper Sandler Healthcare Conference in New York. The presentation will take place at 8:30 a.m. E...
2023-11-01 13:26:04 ET LivaNova PLC (LIVN) Q3 2023 Earnings Conference Call November 1, 2023 8:00 AM ET Company Participants Matthew Dodds - Senior Vice President, Corporate Development & IT Bill Cozy - Chairman and Interim Chief Executive Officer Alex Shvart...
News, Short Squeeze, Breakout and More Instantly...
2024-06-23 00:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its second-quarter 2024 results on Wednesday, July 31, 2024 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its second-quarter 2024 results prior to the call. ...
2024-06-06 11:00:14 ET Rick Wise from Stifel Nicolaus issued a price target of $70.00 for LIVN on 2024-06-06 09:52:00. The adjusted price target was set to $70.00. At the time of the announcement, LIVN was trading at $53.16. The overall price target consensus is at $69.5...